Editor’s Note: The following is an excerpt from the Omaha World-Herald’s article, who recently highlighted how Grasshopper Health is using its Axis PatchTM*, a small, sacrum-based wearable patch, to help track gait changes and refine how chronic diseases, like Parkinson’s Disease, is monitored and managed.
The company’s long-term roadmap also includes expanding into additional conditions; several diseases have known gait associations as well as adjacent fields like sports medicine and physical therapy.
“When former Nebraska running back Ahman Green announced in a recent podcast that he has Parkinson’s disease, he said he had noticed some early signs and sought out doctors for testing.
Even then, his doctors told him they would have thought he was in great shape had they not known to look for some nascent signals, including the way he walked — namely, his gait.
Changes in gait can serve as early warning signs for at least 18 different conditions, including Parkinson’s, Alzheimer’s disease and peripheral artery disease, in which narrowed arteries reduce blood flow to the limbs, typically the legs.”
Click here to read the full story ›
The Axis Patch™ is currently intended for research use only.
About the Author
Lance Stewart
Lance Stewart is Co-Founder and Chief Commercial Officer at Grasshopper Health. With over three decades of experience in pharma, biotech and healthcare technology, Stewart has led commercial strategy, market development and innovation initiatives at global organizations including Merck, McKesson, GNS (now AITIA), SKYGEN USA and CareEvolution. He obtained his bachelor’s degree from the University of Tulsa and completed the Healthcare Executive Program at Kellogg. Stewart specializes in taking transformative medical technologies to market, with deep expertise in early detection, diagnostics and patient-centric care models (including remote monitoring).
